Predictors of clinical and microbiological treatment failure in neonatal bloodstream infections

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
J-F HsuM-H Tsai

Abstract

This study aimed to identify independent predictors of clinical and microbiological treatment failure and develop a predictive model for neonates with bloodstream infection (BSI). This study included 1087 episodes of BSIs in 793 neonates in a tertiary-level neonatal intensive care unit of northern Taiwan between 2004 and 2012. Patient demographics, underlying chronic comorbidities, clinical features, antimicrobial treatment and microbiological characteristics were evaluated. The presence of underlying congenital anomalies (odds ratio [OR] 2.12, 95% confidence interval [CI] 1.09 to 4.10) and pulmonary hypertension (OR 3.63, 95% CI 1.70 to 7.74), infections caused by multidrug-resistant gram-negative bacteria (OR 2.89, 95% CI 1.23 to 6.79), group B Streptococcus (OR 3.15, 95% CI 1.33 to 7.46), and fungi (OR 4.13, 95% CI 2.02 to 8.46), a Neonatal Therapeutic Intervention Scoring System score of ≥ 23 (OR 6.96, 95% CI 2.55 to 28.58), inappropriate antibiotics (OR 2.13, 95% CI 1.41 to 3.23), and concomitant meningitis (OR 4.25, 95% CI 2.08 to 8.69) and ventilator-associated pneumonia (OR 2.73, 95% CI 1.22 to 6.13) were identified as independent risk factors for 28-day treatment failure in neonatal BSI. A risk score model was created ...Continue Reading

References

Oct 7, 2004·Pediatrics·Simon J BroughtonUNKNOWN Neonatal Intensive Care Unit Study Group
Oct 16, 2004·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Anucha ApisarnthanarakVictoria J Fraser
Dec 23, 2004·Archives of Disease in Childhood. Fetal and Neonatal Edition·J S DorlingB Manktelow
Jan 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Imad R MakhoulUNKNOWN Israel Neonatal Network
Jan 6, 2006·The Pediatric Infectious Disease Journal·Adrienne Gordon, David Isaacs
Dec 13, 2006·Pediatrics·John A F ZupancicUNKNOWN Vermont Oxford Network SNAP Pilot Project Participants
Jan 10, 2009·The Pediatric Infectious Disease Journal·Durrane ThaverAnita K M Zaidi
Nov 17, 2009·The Pediatric Infectious Disease Journal·Alberto BerardiUNKNOWN GBS Prevention Working Group of Emilia-Romagna
Dec 3, 2009·The Pediatric Infectious Disease Journal·Michael Cohen-WolkowiezP Brian Smith
Jun 10, 2011·The Pediatric Infectious Disease Journal·Emily J WestonStephanie J Schrag
Jul 29, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A-P MagiorakosD L Monnet
Nov 30, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M N Al-HasanL M Baddour
Jan 9, 2013·Pediatrics·Alberto BerardiUNKNOWN GBS Prevention Working Group, Emilia-Romagna
Nov 20, 2013·Pediatrics·David FisherMartin J McCaffrey
Jan 15, 2014·The Pediatric Infectious Disease Journal·Orly LevitMatthew J Bizzarro
Jan 15, 2014·Pediatrics·Ming-Horng TsaiYhu-Chering Huang

❮ Previous
Next ❯

Citations

Oct 21, 2020·Emerging Infectious Diseases·Shamim A Sinnar, Steven J Schiff
Jul 16, 2019·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Ming-Horng TsaiJang-Jih Lu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Related Papers

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
Majdi N Al-HasanL M Baddour
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
Luan-Ying Tian, Aaron Hamvas
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Pranavi V SreeramojuStephen G Weber
© 2022 Meta ULC. All rights reserved